WHO ICTRP trial
SUNITINIB EITHER BEFORE OR AFTER CYTOREDUCTIVE NEPHRECTOMY A PHASE II TRIAL IN…
EUCTR2007-005977-67-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2007-005977-67-IT |
|---|---|
| Public title | SUNITINIB EITHER BEFORE OR AFTER CYTOREDUCTIVE NEPHRECTOMY A PHASE II TRIAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA - GIR1 |
| Scientific title | SUNITINIB EITHER BEFORE OR AFTER CYTOREDUCTIVE NEPHRECTOMY A PHASE II TRIAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA - GIR1 |
| Primary sponsor | CONSORZIO ONCOTECH |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | Patients with metastatic Renal Cell Carcinoma not previously treated with nephrectomy and systemic therapy. MedDRA version: 9.1 Level: LLT Classification code 10050018 Term: Renal cancer metastatic |
| Interventions | Trade Name: SUTENT*30CPS 50MG Pharmaceutical Form: Capsule, hard INN or Proposed INN: SUNITINIB MALEATO Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 50- |
| Registration date | Nov 2, 2008 |
| Secondary IDs | GIR1 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: